1 Ogino S, "Sensitive sequencing method for KRAS mutation detection by Pyrosequencing" 7 : 413-421, 2005
2 Colella S, "Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites" 35 : 146-150, 2003
3 Ahmadian A, "Pyrosequencing: history, biochemistry and future" 363 : 83-94, 2006
4 Shaw RJ, "Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing" 94 : 561-568, 2006
5 Dong SM, "Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix" 7 : 1982-1986, 2001
6 Bosch FX, "Prevalence of human papillomavirus in cervical cancer: a worldwide perspective international biological study on cervical cancer (IBSCC) study group" 87 : 796-802, 1995
7 Wedge SR, "Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro" 73 : 482-490, 1996
8 Kang S, "Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer" 96 : 173-180, 2005
9 Pollack IF, "O6- methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort" 24 : 3431-3437, 2006
10 Schold SC Jr, "O6- alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts" 70 : 573-577, 1989
1 Ogino S, "Sensitive sequencing method for KRAS mutation detection by Pyrosequencing" 7 : 413-421, 2005
2 Colella S, "Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites" 35 : 146-150, 2003
3 Ahmadian A, "Pyrosequencing: history, biochemistry and future" 363 : 83-94, 2006
4 Shaw RJ, "Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing" 94 : 561-568, 2006
5 Dong SM, "Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix" 7 : 1982-1986, 2001
6 Bosch FX, "Prevalence of human papillomavirus in cervical cancer: a worldwide perspective international biological study on cervical cancer (IBSCC) study group" 87 : 796-802, 1995
7 Wedge SR, "Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro" 73 : 482-490, 1996
8 Kang S, "Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer" 96 : 173-180, 2005
9 Pollack IF, "O6- methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort" 24 : 3431-3437, 2006
10 Schold SC Jr, "O6- alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts" 70 : 573-577, 1989
11 Wolf P, "O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer" 61 : 8113-8117, 2001
12 Woodman CB, "Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study" 357 : 1831-1386, 2001
13 Pegg AE, "Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents" 50 : 6119-6129, 1990
14 Gerson SL, "MGMT: its role in cancer aetiology and cancer therapeutics" 4 : 296-307, 2004
15 Esteller M, "Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia" 59 : 793-797, 1999
16 Zhang YJ, "Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma" 103 : 440-444, 2003
17 Esteller M, "Inactivation of the DNA repair gene O6- methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis" 60 : 2368-2371, 2000
18 Middleton MR, "Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway" 4 : 37-44, 2003
19 Korean Society of Obstetrics and Gynecology, "Gynecologic Oncology Committee. Annual report of gynecologic cancer registry program in Korea for 2004 (Jan. 1st, 2004-Dec. 31st, 2004)" 50 : 28-78, 2007
20 Coulondre C, "Genetic studies of the lac repressor. III. Additional correlation of mutational sites with specific amino acid residues" 117 : 525-567, 1977
21 Middleton MR, "Effect of O6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft model" 100 : 615-617, 2002
22 An Q, "Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients" 188 : 109-114, 2002
23 Citron M, "Detection of messenger RNA from O6-methylguanine-DNA methyltransferase gene MGMT in human normal and tumor tissues" 84 : 337-340, 1992
24 Reesink-Peters N, "Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study" 2 : 289-295, 2004
25 Dolan ME, "Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents" 87 : 5368-5372, 1990
26 Madhusudan S, "DNA repair inhibition: a selective tumour targeting strategy" 11 : 503-511, 2005
27 Robertson KD, "DNA methylation, methyltransferases, and cancer" 20 : 3139-3155, 2001
28 Jemal A, "Cancer statistics" 56 : 106-130, 2006
29 Ministry of Health and Welfare, "Annual report of the Korea central cancer registry (Published in 2003)" 2002
30 Tost J, "Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing" 35 : 152-156, 2003
31 Baylin SB, "Alterations in DNA methylation: a fundamental aspect of neoplasia" 72 : 141-196, 1998
32 Virmani AK, "Aberrant methylation during cervical carcinogenesis" 7 : 584-589, 2001